Instrumento Inactivo

Otros idiomas Kiadis Pharma N.V.

Acciones

Sanofi : Delays Privatization of Kiadis on Pending Mandatory Buy-Out	16/07/21
Pharming benoemt Chief Medical Officer	18/06/21
Certain Ordinary Shares of Kiadis Pharma N.V. are subject to a Lock-Up Agreement Ending on 31-MAY-2021.	31/05/21
Kiadis Pharma N.V.(ENXTAM:KDS) dropped from Next Biotech Index	24/05/21
Kiadis Pharma N : - Notice of Annual General Meeting of Shareholders	14/05/21
Kiadis Pharma N : AGM QA Protocol	13/05/21
Kiadis Pharma N : AGM Agenda	13/05/21
Kiadis Pharma N : AGM Proxy	13/05/21
Sanofi : to Delist Kiadis in Amsterdam, Brussels on May 25	29/04/21
Bijna alle aandelen Kiadis aangemeld onder bod Sanofi	29/04/21
Final results of the Offer for Kiadis: 97.39% of Kiadis Shares in total committed under the Offer	29/04/21
Sanofi : to Delist Kiadis from Euronext on May 25	27/04/21
Sanofi : completes Kiadis acquisition	19/04/21
Sanofi : Closes $368 Million Purchase of Kiadis	19/04/21
Sanofi rondt bod op Kiadis af	16/04/21
Sanofi boucle son OPA amicale sur la biotech néerlandaise Kiadis	16/04/21
Kiadis Pharma N : Minutes of the EGM held on 30 March 2021	14/04/21
Kiadis Pharma N.V.(ENXTAM:KDS) dropped from Netherlands ASCX AMS Small Cap Index	14/04/21
Sanofi : Declares Kiadis Offer Unconditional, All Offer Conditions Now Satisfied	13/04/21
Sanofi : Declares Offer for Immunotherapy Company Kiadis Unconditional	13/04/21

No hay resultados para esta búsqueda